DP
AYTU icon

Diadema Partners’s AYTU BioPharma AYTU Stock Holding History

Diadema Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$964K Buy
353,077
+47,289
+15% +$121K 0.16% 86
2025
Q4 		$795K Buy
305,788
+33,118
+12% +$74.3K 0.14% 99
2025
Q3 		$513K Buy
+272,670
New +$630K 0.13% 98

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Diadema Partners's AYTU Position: Q1 2026 in Review

Diadema Partners increased its AYTU BioPharma (AYTU) stake by 15% in Q1 2026, buying an estimated $121K and bringing the position to 353,077 shares worth $964K. The position accounts for 0.16% of the portfolio, ranked #86.

Diadema Partners first reported a position in AYTU in Q3 2025 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Diadema Partners held 353,077 shares of AYTU BioPharma worth $964K as of Q1 2026.
  • Diadema Partners bought 47,289 AYTU BioPharma shares in Q1 2026, an estimated $121K.
  • AYTU BioPharma made up 0.16% of Diadema Partners's portfolio in Q1 2026, its #86 holding.
  • Diadema Partners first reported a position in AYTU BioPharma in Q3 2025 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.